Brain tumor magnetic resonance spectroscopy NCD
This article was originally published in The Gray Sheet
Executive Summary
Decision date is delayed until Nov. 28 to "permit additional review and clearances," CMS announces Oct. 30. An AHRQ tech assessment found that limited availability of the indicated condition has made it difficult to undertake the clinical trials required for national coverage (1"The Gray Sheet" June 23, 2003, p. 24)...